A modification and inducing endothelial cell inflammatory response as well as atherosclerotic plaque formation. Decreased expression of METTL14 can inhibit endothelial inflammation and atherosclerosis development. Therefore, METTL14 may serve as a potential target for the clinical treatment of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Jian et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: